These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36379113)

  • 1. Quality assessment of niosomal suspensions.
    Ježková M; Šrom O; George AH; Kereïche S; Rohlíček J; Šoóš M
    J Colloid Interface Sci; 2023 Feb; 631(Pt B):22-32. PubMed ID: 36379113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of bilayer membrane and niosomes by double-tailed polyglyceryl-type nonionic surfactant.
    Aramaki K; Yamada J; Tsukijima Y; Maehara T; Aburano D; Sakanishi Y; Kitao K
    Langmuir; 2015 Oct; 31(39):10664-71. PubMed ID: 26355349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR; Elkordy AA; Chaw CS
    Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Encapsulation of Leflunomide (LFD) in a novel niosomal formulation facilitated its delivery to THP-1 monocytic cells and enhanced Aryl hydrocarbon receptor (AhR) nuclear translocation and activation.
    Hasani M; Sani NA; Khodabakhshi B; Arabi MS; Mohammadi S; Yazdani Y
    Daru; 2019 Dec; 27(2):635-644. PubMed ID: 31432467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of curcumin-Cu and curcumin-Ag nanoparticle loaded niosome: Enhanced antibacterial and anti-biofilm activities.
    Targhi AA; Moammeri A; Jamshidifar E; Abbaspour K; Sadeghi S; Lamakani L; Akbarzadeh I
    Bioorg Chem; 2021 Oct; 115():105116. PubMed ID: 34333420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced nuclear translocation and activation of aryl hydrocarbon receptor (AhR) in THP-1 monocytic cell line by a novel niosomal formulation of indole-3-carbinol.
    Abbaspour Sani N; Hasani M; Kianmehr A; Mohammadi S; Sheikh Arabi M; Yazdani Y
    J Liposome Res; 2020 Jun; 30(2):117-125. PubMed ID: 30917715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Effect of a Small Hydrophobic Drug (Cinnarizine) on the Physicochemical Characterisation of Niosomes Produced by Thin-Film Hydration and Microfluidic Methods.
    Yeo LK; Olusanya TOB; Chaw CS; Elkordy AA
    Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30322124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorbitan ester niosomes for topical delivery of rofecoxib.
    Das MK; Palei NN
    Indian J Exp Biol; 2011 Jun; 49(6):438-45. PubMed ID: 21702223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in vitro characterization of niosomal formulations of immunosuppressant model drug.
    Rehman M; Rasul A; Waqas MK; Khan MI; Sher M
    Pak J Pharm Sci; 2018 Nov; 31(6 (Supplementary):2623-2628. PubMed ID: 30587470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of niosomal formulations of doxorubicin aimed at brain targeting.
    Bragagni M; Mennini N; Ghelardini C; Mura P
    J Pharm Pharm Sci; 2012; 15(1):184-96. PubMed ID: 22365096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery.
    Balakrishnan P; Shanmugam S; Lee WS; Lee WM; Kim JO; Oh DH; Kim DD; Kim JS; Yoo BK; Choi HG; Woo JS; Yong CS
    Int J Pharm; 2009 Jul; 377(1-2):1-8. PubMed ID: 19394413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Entrapment enhancement of peptide drugs in niosomes.
    Manosroi A; Khanrin P; Werner RG; Götz F; Manosroi W; Manosroi J
    J Microencapsul; 2010 May; 27(3):272-80. PubMed ID: 20113169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
    Patel KK; Kumar P; Thakkar HP
    AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained transdermal delivery of human growth hormone from niosomal gel:
    Wang L; Wei L; Long W; Zhang Q; Zou Y
    J Biomater Sci Polym Ed; 2022 Jun; 33(9):1198-1212. PubMed ID: 35192434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and evaluation of a buflomedil hydrochloride niosomal patch for transdermal delivery.
    Akhtar N; Arkvanshi S; Bhattacharya SS; Verma A; Pathak K
    J Liposome Res; 2015 Sep; 25(3):191-201. PubMed ID: 25357198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Green tea catechin loaded niosomes: formulation and their characterization for food fortification.
    Gadapa S; Battula SN; Mor S; Pushpadass HA; Naik LN; Emerald ME
    J Food Sci Technol; 2022 Sep; 59(9):3669-3682. PubMed ID: 35875240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes.
    Taymouri S; Varshosaz J
    Adv Biomed Res; 2016; 5():48. PubMed ID: 27110545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
    Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
    Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.